If you are interested in our services or solutions, please do not hesitate to contact us. We will get back to you as soon as possible.
Contact NowLiquid-liquid phase separation (LLPS) is a phase change that is important in living organisms and is a unique way to form biomolecular condensates. When a cell releases a recruitment signal at a specific range and time, the original dispersed protein must undergo certain changes in order to "aggregate". After performing its function, the protein accepts the new signal and returns to solution without altering the existing intracellular protein expression level. Therefore, rapid protein post-translational modification (PTM) is an ideal way to regulate phase separation. PTM can modify the structure, charge, hydrophobicity and other properties of the proteins involved in phase separation, thus affecting phase transition behavior. The study of LLPS is still in its infancy, and the regulation of LLPS by PTM will undoubtedly be the focus of future research.
Fig. 1. Phosphorylation in LLPS. (Li J, et al., 2022)
PTM can change the spatial structural properties, charge state and volume of the modified amino acids, thus affecting the activity state, localization, flip-flop and protein-protein interactions of the whole protein. Therefore, how PTM affects LLPS-induced bioaggregates is of great interest to us. Here at CD BioSciences, we can help our customers analyze the regulation of LLPS by various PTMs, including but not limited to:
RNA-binding proteins also undergo regulated phase transitions in a range of cell types. We also work to analyze the role of PTM in regulating RNA-binding protein condensation.
We can help you systematically understand the relationship between post-translational protein modifications and phase separation, and focus more on the changes in physical properties induced by the modifications in regulating phase separation. If you are interested in our services, please do not hesitate to contact us for more information.
Reference
CD BioSciences is a company conducting biomolecular condensates targeted innovative drugs. We integrate the latest advances in physics, chemistry, biology, and machine learning to address some of the most fundamental challenges in health and disease today.
Address:
Tel:
Email: